Rentokil Initial PLC (NYSE:RTO – Get Free Report) has received an average rating of “Hold” from the thirteen analysts that are currently covering the stock, MarketBeat Ratings reports. Two research analysts have rated the stock with a sell rating, four have given a hold rating and seven have assigned a buy rating to the company. The average 12 month target price among brokers that have issued ratings on the stock in the last year is $31.90.
A number of research analysts recently commented on the company. Morgan Stanley cut Rentokil Initial from an “overweight” rating to an “equal weight” rating in a report on Tuesday, September 29th. Investec upgraded Rentokil Initial to a “buy” rating in a report on Wednesday, September 23rd. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating on shares of Rentokil Initial in a report on Monday, August 3rd. BNP Paribas Exane lowered shares of Rentokil Initial from an “outperform” rating to a “neutral” rating and set a $26.70 target price for the company. in a research note on Friday, July 31st. Finally, Stifel Nicolaus raised Rentokil Initial from a “hold” rating to a “buy” rating in a research note on Monday, October 5th.
Check Out Our Latest Analysis on Rentokil Initial
Rentokil Initial Stock Up 0.6%
Shares of NYSE:RTO opened at $21.22 on Tuesday. The company has a current ratio of 1.06, a quick ratio of 0.98 and a debt-to-equity ratio of 0.65. The stock has a 50 day moving average of $22.13 and a 200 day moving average of $27.59. Rentokil Initial has a 12-month low of $19.50 and a 12-month high of $34.67.
Rentokil Initial Cuts Dividend
The business also recently disclosed a dividend, which was paid on Tuesday, September 22nd. Investors of record on Friday, August 14th were given a dividend of $0.2240 per share. The ex-dividend date of this dividend was Friday, August 14th. This is a decrease from Rentokil Initial’s previous dividend of $0.4120. This represents a yield of 188.0%.
Institutional Inflows and Outflows
Several hedge funds have recently added to or reduced their stakes in RTO. Continuum Advisory LLC acquired a new stake in Rentokil Initial during the 2nd quarter worth about $42,000. V Square Quantitative Management LLC increased its holdings in shares of Rentokil Initial by 84.5% during the 1st quarter. V Square Quantitative Management LLC now owns 1,395 shares of the company’s stock valued at $44,000 after purchasing an additional 639 shares in the last quarter. Integrated Wealth Concepts LLC purchased a new stake in shares of Rentokil Initial during the 2nd quarter worth about $57,000. Parallel Advisors LLC lifted its position in shares of Rentokil Initial by 50.5% during the 1st quarter. Parallel Advisors LLC now owns 2,107 shares of the company’s stock valued at $66,000 after buying an additional 707 shares in the last quarter. Finally, Fifth Third Bancorp acquired a new stake in Rentokil Initial in the 1st quarter worth about $83,000. 9.91% of the stock is owned by institutional investors and hedge funds.
About Rentokil Initial
Rentokil Initial plc (NYSE:RTO) is a business services company headquartered in the United Kingdom. It provides pest control, hygiene, and workplace services to commercial, public-sector, and residential customers. Its offerings are designed to help organizations manage pests, maintain sanitary environments, and support health, safety, and workplace standards.
The company’s pest control services address insects, rodents, and other pests, while its hygiene operations provide washroom services, sanitary products, air care, floor-care solutions, and related workplace services.
Recommended Stories
- Five stocks we like better than Rentokil Initial
- Amprius Technologies’ Next Big Rally Could Be Taking Shape
- 4 Stocks With Demand So Sticky That the AI Sell-Off Barely Touched Them at All
- Tesla’s Roadster Reveal Hints at 2 Much Bigger Moves
- The AI Sell-Off Continues—These 3 Stocks Keep Raising Guidance Anyway
Receive News & Ratings for Rentokil Initial Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rentokil Initial and related companies with MarketBeat.com's FREE daily email newsletter.
